Study type
Nutrition and metabolism studies recruiting now
Nutrition and metabolism studies look at diets, supplements, metabolic conditions and fatty liver disease. Some are run by universities with controlled meals.
361 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Regeneron Pharmaceuticals
- Location
- Tucson, AZ + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
CorMedix Therapeutics
- Location
- Los Angeles, CA + 16 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Altimmune, Inc.
- Location
- North Little Rock, AR + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
CRISPR Therapeutics AG
- Location
- Hialeah, FL + 7 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Arcadia, CA + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study of Resmetirom in Children and Adolescents With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Kriya Therapeutics, Inc.
- Location
- Lady Lake, FL
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- La Jolla, CA + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Protara Therapeutics
- Location
- Aurora, CO + 5 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1/Phase 2
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Otsuka Pharmaceutical Factory, Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 35–70
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Chandler, AZ + 28 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Regeneron Pharmaceuticals
- Location
- Chandler, AZ + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 24 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Stem Cell Ophthalmology Treatment Study II
MD Stem Cells
- Location
- Westport, CT + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
MBX Biosciences
- Location
- Doral, FL + 3 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
GlaxoSmithKline
- Location
- Rialto, CA + 2 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
SterileCare Inc.
- Location
- Boston, MA + 6 other US sites
- Eligibility basics
- Ages 1 mo–18
- Recruiting
At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism
Sequitur Health Corp.
- Location
- Portland, OR
- Eligibility basics
- Ages 12+
- Recruiting
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Perspectum
- Location
- Chandler, AZ + 5 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Rivus Pharmaceuticals, Inc.
- Location
- Chandler, AZ + 30 other US sites
- Eligibility basics
- Ages 30+
- Recruiting
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Kate Farms Inc
- Location
- Seattle, WA
- Eligibility basics
- Ages 1–21
- RecruitingPhase 1/Phase 2
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
ModernaTX, Inc.
- Location
- Palo Alto, CA + 5 other US sites
- Eligibility basics
- Ages 1+
Who these studies look for
Expect limits on supplements, alcohol and diet changes during the study, and sometimes a set BMI range.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Are meals provided in nutrition studies?
Sometimes. Controlled-feeding studies provide food; others ask you to follow a plan at home. The listing summary and the study team explain what is involved.